Proteomic analysis of human bile and potential applications for cancer diagnosis.
about
Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomicsInvestigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.Bile formation and secretion.Identification of pancreas-specific proteins in endoscopically (endoscopic pancreatic function test) collected pancreatic fluid with liquid chromatography--tandem mass spectrometry.Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass SpectrometryComparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma.Protein analysis by shotgun/bottom-up proteomicsHuman bile as a rich source of biomarkers for hepatopancreatobiliary cancers.Cancer proteomics.Bile proteome in health and disease.Functional Immune Anatomy of the Liver-As an Allograft.Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.Encapsulation of Antifungals in Micelles Protects Candida albicans during Gall-Bladder Infection.Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver InjuryDifferent expression of S100A8 in malignant and benign gallbladder diseases.Shotgun proteomics of human bile in hilar cholangiocarcinoma.The food-borne pathogen Campylobacter jejuni responds to the bile salt deoxycholate with countermeasures to reactive oxygen species.Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis.Composition of gallbladder bile in healthy individuals and patients with gallstone disease from north and South India.Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantation.Novel Potential Biomarkers for Infection and Associated Cholangiocarcinoma
P2860
Q33591231-4FEB9483-C474-47C2-9F81-E3237BFF87C3Q33605010-93CD631B-90DB-476D-B5E4-2600B82874FBQ33881922-954B4427-AB71-4BB1-8039-17B778F70707Q33937479-34B40C4B-65D3-49A0-99D6-47AFB74D3E5FQ34377996-6A7D07C4-059F-4295-91A9-B10CEB124DA1Q34464452-8E2885FA-22BB-4042-A396-0311B835BEAAQ34600986-5A581B2A-FB80-4739-AA99-0AF669200394Q37734427-97E66368-7B66-429F-A4F7-365F9F4D8962Q37994133-AE519B06-175C-4078-98A4-A1EAFDEFA0CFQ38201380-215FC662-A848-4794-A528-72D5D914ACCDQ38723925-1DAD2B20-5D45-46E8-B7DB-D6EAE9608469Q39775602-F89186D4-6DD7-4281-B0C3-05EC19FA9227Q40331132-9C75675B-E7E6-4140-B2F3-CA6D0FACE6CCQ41762406-D1CB8016-6BE2-4A35-9F9F-3B1013A847B4Q43906599-7FD7D39F-B663-45B8-8F37-E3B5F4BE8217Q44226984-383AAE22-8CA7-46D9-A8B9-45B96B8EE6B3Q46262353-3A605DA5-A58C-43C4-AE0B-BC2E4607B1E0Q47400929-4EB65E41-54D0-455F-A208-567531212305Q50160393-4318174D-3F51-49E6-A87D-3BE724697AEDQ51681229-097150CE-8447-42F6-A054-E61950195303Q57115768-3CDB691D-BE14-4892-B385-3484300C5972
P2860
Proteomic analysis of human bile and potential applications for cancer diagnosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomic analysis of human bile and potential applications for cancer diagnosis.
@en
Proteomic analysis of human bile and potential applications for cancer diagnosis.
@nl
type
label
Proteomic analysis of human bile and potential applications for cancer diagnosis.
@en
Proteomic analysis of human bile and potential applications for cancer diagnosis.
@nl
prefLabel
Proteomic analysis of human bile and potential applications for cancer diagnosis.
@en
Proteomic analysis of human bile and potential applications for cancer diagnosis.
@nl
P2860
P50
P356
P1476
Proteomic analysis of human bile and potential applications for cancer diagnosis
@en
P2093
Annarita Farina
P2860
P304
P356
10.1586/EPR.09.12
P577
2009-06-01T00:00:00Z